Plus Therapeutics Inc [PSTV] stock is trading at $0.52, down -2.42%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The PSTV shares have lost -28.42% over the last week, with a monthly amount glided 36.22%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Plus Therapeutics Inc [NASDAQ: PSTV] stock has seen the most recent analyst activity on March 17, 2025, when D. Boral Capital initiated its Buy rating and assigned the stock a price target of $9. Previously, Ladenburg Thalmann started tracking the stock with Buy rating on January 25, 2021, and set its price target to $8. On October 16, 2020, Maxim Group initiated with a Buy rating and assigned a price target of $6 on the stock.
Plus Therapeutics Inc [PSTV] stock has fluctuated between $0.16 and $2.31 over the past year. Plus Therapeutics Inc [NASDAQ: PSTV] shares were valued at $0.52 at the most recent close of the market.
Analyzing the PSTV fundamentals
Plus Therapeutics Inc [NASDAQ:PSTV] reported sales of 5.32M for the trailing twelve months, which represents a growth of 8.68%. Gross Profit Margin for this corporation currently stands at -0.26% with Operating Profit Margin at -6.39%, Pretax Profit Margin comes in at -11.6%, and Net Profit Margin reading is -11.6%. To continue investigating profitability, this company’s Return on Assets is posted at -2.25, Equity is 2.39 and Total Capital is -9.97. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at -0.0.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 0.4982 points at the first support level, and at 0.4733 for the second support level. However, for the 1st resistance point, the stock is sitting at 0.5498, and for the 2nd resistance point, it is at 0.5765.
Ratios To Look Out For
For context, Plus Therapeutics Inc’s Current Ratio is 1.20. As well, the Quick Ratio is 1.20, while the Cash Ratio is 0.93. Considering the valuation of this stock, the price to sales ratio is 9.76, the price to book ratio is 15.89.
Transactions by insiders
Recent insider trading involved Petersen Greg, Director, that happened on May 15 ’25 when 36666.0 shares were purchased. Director, Hawkins Richard J completed a deal on Sep 13 ’24 to buy 4000.0 shares. Meanwhile, Director Hawkins Richard J bought 6285.0 shares on Sep 12 ’24.
